These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 17257673)

  • 1. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
    Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstöcker M; Rüter B; Sperr WR; Stauder R; Wells DA
    Leuk Res; 2007 Jun; 31(6):727-36. PubMed ID: 17257673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.
    Valent P; Horny HP
    Eur J Clin Invest; 2009 Jul; 39(7):548-53. PubMed ID: 19453651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop.
    Platzbecker U; Santini V; Mufti GJ; Haferlach C; Maciejewski JP; Park S; Solé F; van de Loosdrecht AA; Haase D
    Leuk Res; 2012 Mar; 36(3):264-70. PubMed ID: 22137318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.
    Valent P; Akin C; Escribano L; Födinger M; Hartmann K; Brockow K; Castells M; Sperr WR; Kluin-Nelemans HC; Hamdy NA; Lortholary O; Robyn J; van Doormaal J; Sotlar K; Hauswirth AW; Arock M; Hermine O; Hellmann A; Triggiani M; Niedoszytko M; Schwartz LB; Orfao A; Horny HP; Metcalfe DD
    Eur J Clin Invest; 2007 Jun; 37(6):435-53. PubMed ID: 17537151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes.
    Schiffer CA
    Semin Hematol; 2008 Jan; 45(1):3-7. PubMed ID: 18179963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.
    Wimazal F; Fonatsch C; Thalhammer R; Schwarzinger I; Müllauer L; Sperr WR; Bennett JM; Valent P
    Leuk Res; 2007 Nov; 31(11):1461-8. PubMed ID: 17507091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic scoring systems for risk assessment in myelodysplastic syndromes.
    Greenberg PL; Sanz GF; Sanz MA
    Forum (Genova); 1999; 9(1):17-31. PubMed ID: 10101208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response assessments in low-risk and high-risk myelodysplastic syndromes (MDS).
    Fenaux P
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S11-5. PubMed ID: 16085012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric myelodysplastic syndromes.
    Rytting ME
    Curr Hematol Rep; 2004 May; 3(3):173-7. PubMed ID: 15087064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.
    Silverman LR; McKenzie DR; Peterson BL; Holland JF; Backstrom JT; Beach CL; Larson RA;
    J Clin Oncol; 2006 Aug; 24(24):3895-903. PubMed ID: 16921040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS.
    Valent P; Bain BJ; Bennett JM; Wimazal F; Sperr WR; Mufti G; Horny HP
    Leuk Res; 2012 Jan; 36(1):1-5. PubMed ID: 21920601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving classifications of the myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Opin Hematol; 2007 Mar; 14(2):98-105. PubMed ID: 17255786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
    Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
    Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes.
    Aul C; Giagounidis A; Heinsch M; Germing U; Ganser A
    Rev Clin Exp Hematol; 2004 Dec; 8(2):E1. PubMed ID: 16027099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment.
    Pilo F; Di Tucci AA; Dessalvi P; Caddori A; Angelucci E
    Eur J Intern Med; 2010 Dec; 21(6):490-5. PubMed ID: 21111932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes.
    Foran JM; Shammo JM
    Am J Med; 2012 Jul; 125(7 Suppl):S6-13. PubMed ID: 22735753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel therapies for myelodysplastic syndromes.
    Faderl S; Kantarjian HM
    Cancer; 2004 Jul; 101(2):226-41. PubMed ID: 15241818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelodysplastic syndromes].
    Paladini G; Pecorari P; De Sabbata G; Sammartini C
    Recenti Prog Med; 2004 Feb; 95(2):108-19. PubMed ID: 15072397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of myelodysplastic syndromes in cytopenic patients.
    Wang SA
    Hematol Oncol Clin North Am; 2011 Oct; 25(5):1085-110, vii. PubMed ID: 22054736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.